Invivo Therapeutics (NVIV) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts NVIV Hot Sheet
Join SI Premium – FREE
Invivo Therapeutics (NASDAQ: NVIV) reported Q3 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Invivo Therapeutics (NVIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
